350. L'existence de differences en

350. L'existence de differences entre les molecules a d'ailleurs ete relevee par la CNAMTS elle-meme

dans son point presse du 6 juin 2012 189

qui evoque pour le « NS », «des variations importantes



185 Le detail de ces temoignages a ete repris dans le Memoire recapitulatif de Sanofi-Aventis France du 21 septembre 2012 devant I'ADLC, pt. 457.
186 Decision, pt. 517.
187 Decision, pt. 122.
188 Decision, pt. 523.

Résultats (Anglais) 1:

350. the existence of differences between the molecules has also been noted by CNAMTS itself

in his press conference June 6, 2012 189

which evokes for "ns", "significant changes



185 the detail of the testimony was taken in the recapitulatif memory of the sanofi-aventis France i'adlc before September 21, 2012, pt. 457.
186 decision, pt. 517.
187 decision, pt. 122.
188 decision, pt.
523.

Résultats (Anglais) 2:

350. The existence of differences between molecules has been identified by the CNAMTS itself

in his newsstand on June 6, 2012 189

which evoque for 'NS', ' significant variations



185 retail of these accounts has been included in the summary Bill of Sanofi-Aventis France September 21, 2012 before I'ADLC, PT.. 457
186 Decision, pt. 517
187 Decision, pt. 122
188 Decision, pt. 523.

Résultats (Anglais) 3:

350. The existence of differences between the molecules has also been raised by the CNAMTS itself

in his press point of the June 6, 2012 189

who referred to the "NS", "significant variations
pretender 185 The detail of these testimonies has been resumed in the brief summary of Sanofi-Aventis France of the September 21, 2012 before I'when compressed using ADLC, pt. 457.
186 Decision, pt. 517.
187 Decision, pt. 122.
188 Decision, pt. 523.